Clinical outcomes and dosimetric study of hypofractionated Helical TomoTherapy in breast cancer patients

Abstract

We present a single center’s experience of treatment outcomes and dosimetric parameters for breast cancer patients treated with hypofractionated Helical TomoTherapy (HT). This is a retrospective study of one hundred and thirty-six patients with invasive breast cancer treated between March 2012 and October 2016. Dosimetric parameters and 3-year loco-regional failure free survival (LRFFS) were analyzed. Dose to ipsilateral lung, heart and contralateral breast as well as acute and late toxicities were recorded. The median follow-up time is 45 months (range: 5–83). Two patients had loco-regional failure. The 3-year LRFFS was 99%. Acute grade 1 and 2 skin toxicities occurred in 95% and 1%, respectively. Coverage of the target volumes was achieved with the mean ± standard deviation (SD) of homogeneity and conformity index being 0.1 ± 0.04, and 0.8 ± 0.07, respectively. Dose to ipsilateral lung, contralateral breast, and heart was also within the limited constraints regardless of the complexity of target volumes. Only two percent of patients experienced late grade 2 skin toxicity. No late grade 2 subcutaneous tissue toxicity was found. Nine percent of patients developed late grade 1 lung toxicity. Hypofractionated radiotherapy using Helical TomoTherapy in breast irradiation provides excellent 3-year LRFFS and minimal acute and late toxicities. A careful, longer follow-up of healthy tissue effects to lung, heart, and contralateral breast is warranted.

Tailored Ge-doped fibres for passive electron radiotherapy dosimetry

“…In delivering a prescribed radiation dose to a well-defined target, the imperative (that of the International Commission on Radiological Units, ICRU) [ 1 ] is to achieve accuracy to within < 5% while at the same time minimizing dose to surrounding healthy tissue, a matter discussed in detail by Kry et al (2017) [ 2 ]. It has become much more complex to manage the dosimetry of the novel techniques of advancing radiotherapy including small and microbeam therapies [ 3 – 4 ], hypo-fractionation [ 5 ]and FLASH radiotherapy [ 6 ]. This is due to the various influencing factors which necessarily effect the ability to achieve such accuracy.…”

Dosimetric comparison of TomoDirect, helical tomotherapy, and volumetric modulated arc therapy for postmastectomy treatment

“…depth and posterior x‐ray field prescribed point at midline depth was used for axillary nodes combined with anterior electrons to treat internal mammary nodes. Subsequently, helical tomotherapy (HT) often becomes the treatment of choice for PMRT due to improved conformality to the target, while sparing the OARs 2 …”

Comparing dosimetric and cancer control outcomes after intensity‑modulated radiation therapy and tomotherapy for advanced cervical cancer

“…The CI value is typically 0–1, and the closer it is to 1, the better the conformability of the PTV. A larger HI represents worse PTV heterogeneity ( 21 , 22 ). The present study results showed that compared with intensity-modulated radiotherapy, TOMO produced a significant improvement in dose conformity (0.82±0.0327 vs. 0.75±0.064, respectively; P=0.006) and homogeneity (1.03±0.006 vs. 1.09±0.076, respectively; P<0.001).…”